Alain Duhamel

Targeting chelatable iron as a therapeutic modality in Parkinson's disease.

J. Corvol, J. Kluza, F. Auger, 2014, Antioxidants & redox signaling.

Brain metabolic abnormalities during gait with freezing in Parkinson’s disease

L. Defebvre, K. Dujardin, D. Devos, 2015, Neuroscience.

Influence of chronic administration of L-DOPA on event-related desynchronization of mu rhythm preceding voluntary movement in Parkinson's disease.

J D Guieu, P. Derambure, L. Defebvre, 1998, Electroencephalography and clinical neurophysiology.

Statistical tools for clinical gait analysis.

P Devos, P. Derambure, L. Defebvre, 2004, Gait & posture.

Vigilance troubles in Parkinson's disease: a subjective and objective polysomnographic study.

P. Derambure, L. Defebvre, J. Jacquesson, 2006, Sleep medicine.

EXHAUSTIVE, ONE‐YEAR FOLLOW‐UP OF SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION IN A LARGE, SINGLE‐CENTER COHORT OF PARKINSONIAN PATIENTS

P. Krystkowiak, F. Cassim, G. Touzet, 2007, Neurosurgery.